MRPL43
gene geneOn this page
Also known as bMRP36amL43
Summary
MRPL43 (mitochondrial ribosomal protein L43, HGNC:14517) is a protein-coding gene on chromosome 10q24.31, encoding Large ribosomal subunit protein mL43 (Q8N983). It is a selective cancer dependency (DepMap: 77.2% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. This gene and the gene for a semaphorin class 4 protein (SEMA4G) overlap at map location 10q24.31 and are transcribed in opposite directions. Sequence analysis identified multiple transcript variants encoding at least four different protein isoforms.
Source: NCBI Gene 84545 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 145 total
- Cancer dependency (DepMap): dependent in 77.2% of screened cell lines
- MANE Select transcript:
NM_032112
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14517 |
| Approved symbol | MRPL43 |
| Name | mitochondrial ribosomal protein L43 |
| Location | 10q24.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bMRP36a, mL43 |
| Ensembl gene | ENSG00000055950 |
| Ensembl biotype | protein_coding |
| OMIM | 611848 |
| Entrez | 84545 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 14 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000299179, ENST00000318325, ENST00000318364, ENST00000342071, ENST00000370234, ENST00000370236, ENST00000370241, ENST00000370242, ENST00000448244, ENST00000476012, ENST00000477279, ENST00000487059, ENST00000493646, ENST00000523148, ENST00000858454, ENST00000915453, ENST00000952360
RefSeq mRNA: 8 — MANE Select: NM_032112
NM_001308396, NM_001394981, NM_001394982, NM_001394983, NM_032112, NM_176792, NM_176793, NM_176794
CCDS: CCDS7502, CCDS7503, CCDS7504, CCDS7505, CCDS76331, CCDS91321, CCDS91322
Canonical transcript exons
ENST00000318364 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001277968 | 100987090 | 100987196 |
| ENSE00001900571 | 100987313 | 100987497 |
| ENSE00003548935 | 100986269 | 100986975 |
Expression profiles
Bgee: expression breadth ubiquitous, 262 present calls, max score 97.41.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 81.6297 / max 282.3576, expressed in 1826 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 111072 | 79.8758 | 1825 |
| 111069 | 1.2701 | 815 |
| 111070 | 0.3619 | 139 |
| 111071 | 0.1219 | 22 |
Top tissues by expression
263 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 97.41 | gold quality |
| left testis | UBERON:0004533 | 97.09 | gold quality |
| right testis | UBERON:0004534 | 96.85 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.74 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.66 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.55 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.52 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.46 | gold quality |
| kidney epithelium | UBERON:0004819 | 96.43 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.40 | gold quality |
| upper arm skin | UBERON:0004263 | 96.32 | gold quality |
| right uterine tube | UBERON:0001302 | 96.19 | gold quality |
| adrenal cortex | UBERON:0001235 | 96.16 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.12 | gold quality |
| muscle of leg | UBERON:0001383 | 96.11 | gold quality |
| body of pancreas | UBERON:0001150 | 96.07 | gold quality |
| endocervix | UBERON:0000458 | 96.02 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.01 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 96.00 | gold quality |
| left ovary | UBERON:0002119 | 95.95 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 95.95 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.92 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.86 | gold quality |
| testis | UBERON:0000473 | 95.83 | gold quality |
| body of stomach | UBERON:0001161 | 95.83 | gold quality |
| lower esophagus | UBERON:0013473 | 95.81 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 95.81 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 95.81 | gold quality |
| right ovary | UBERON:0002118 | 95.77 | gold quality |
| spinal cord | UBERON:0002240 | 95.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 12.66 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting MRPL43, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
| HSA-MIR-3617-5P | 99.75 | 69.41 | 1968 |
| HSA-MIR-641 | 99.75 | 69.35 | 1975 |
| HSA-MIR-5004-3P | 99.54 | 68.27 | 1371 |
| HSA-MIR-377-3P | 99.37 | 70.18 | 1905 |
| HSA-MIR-548AS-3P | 99.12 | 69.12 | 2294 |
| HSA-MIR-153-3P | 98.96 | 72.51 | 1644 |
| HSA-MIR-4501 | 98.72 | 67.19 | 921 |
| HSA-MIR-1261 | 98.62 | 68.10 | 896 |
| HSA-MIR-1304-3P | 98.29 | 66.44 | 1207 |
| HSA-MIR-6072 | 98.00 | 66.47 | 804 |
| HSA-MIR-649 | 97.96 | 67.21 | 704 |
| HSA-MIR-6800-3P | 96.15 | 65.16 | 461 |
| HSA-MIR-6891-3P | 95.80 | 65.76 | 683 |
| HSA-MIR-6813-3P | 95.78 | 63.78 | 540 |
| HSA-MIR-6808-3P | 94.13 | 65.24 | 516 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 77.2% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 3)
- miR-608 rs4919510 Polymorphism May Affect Susceptibility to Colorectal Cancer by Upregulating MRPL43 Expression. (PMID:33147064)
- Antagonistic regulatory effects of a single cis-acting expression quantitative trait locus between transcription and translation of the MRPL43 gene. (PMID:35659240)
- Network-based meta-analysis and the candidate gene association studies reveal novel ethnicity-specific variants in MFSD3 and MRPL43 associated with dementia with Lewy bodies. (PMID:35765761)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrpl43 | ENSDARG00000076334 |
| mus_musculus | Mrpl43 | ENSMUSG00000025208 |
| rattus_norvegicus | Mrpl43 | ENSRNOG00000014890 |
| drosophila_melanogaster | mRpL43 | FBGN0034893 |
| caenorhabditis_elegans | mrpl-34 | WBGENE00007712 |
Protein
Protein identifiers
Large ribosomal subunit protein mL43 — Q8N983 (reviewed: Q8N983)
Alternative names: 39S ribosomal protein L43, mitochondrial, Mitochondrial ribosomal protein bMRP36a
All UniProt accessions (5): B1AL05, Q8N983, H0Y6Y8, H0YBU8, M0R051
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial large ribosomal subunit (mt-LSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Tissue specificity. High relative levels in skeletal muscle and testis. Lower levels of expression in the heart, brain, placenta, lung, liver, kidney, pancreas, spleen, thymus, prostate, ovary, small intestine, colon and leukocytes. Expression is coregulated with TWNK.
Similarity. Belongs to the mitochondrion-specific ribosomal protein mL43 family.
Isoforms (6)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N983-1 | 1 | yes |
| Q8N983-2 | 2 | |
| Q8N983-3 | 3 | |
| Q8N983-4 | 4 | |
| Q8N983-6 | 5 | |
| Q8N983-7 | 6 |
RefSeq proteins (8): NP_001295325, NP_001381910, NP_001381911, NP_001381912, NP_115488, NP_789762, NP_789763, NP_789764 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007741 | Ribosomal_mL43/mS25/NADH_DH | Domain |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
| IPR039927 | Ribosomal_mL43 | Family |
Pfam: PF05047
UniProt features (26 total): strand 9, splice variant 7, helix 5, turn 3, transit peptide 1, chain 1
Structure
Experimental structures (PDB)
85 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7OF0 | ELECTRON MICROSCOPY | 2.2 |
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 8QU5 | ELECTRON MICROSCOPY | 2.42 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 7OF7 | ELECTRON MICROSCOPY | 2.5 |
| 7PO4 | ELECTRON MICROSCOPY | 2.56 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7O9M | ELECTRON MICROSCOPY | 2.6 |
| 7OF6 | ELECTRON MICROSCOPY | 2.6 |
| 9CN3 | ELECTRON MICROSCOPY | 2.62 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 7OF2 | ELECTRON MICROSCOPY | 2.7 |
| 7OF3 | ELECTRON MICROSCOPY | 2.7 |
| 7OF4 | ELECTRON MICROSCOPY | 2.7 |
| 9PR4 | ELECTRON MICROSCOPY | 2.77 |
| 9PRA | ELECTRON MICROSCOPY | 2.83 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7QH7 | ELECTRON MICROSCOPY | 2.89 |
| 7ODR | ELECTRON MICROSCOPY | 2.9 |
| 7OF5 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 8OIT | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N983-F1 | 84.03 | 0.70 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 88 (showing top):
GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, GGAANCGGAANY_UNKNOWN, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, HNF1_C, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOCC_LARGE_RIBOSOMAL_SUBUNIT, GOCC_RIBOSOME, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial ribosome (GO:0005761), mitochondrial large ribosomal subunit (GO:0005762), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar ribosome | 1 |
| mitochondrial matrix | 1 |
| organellar large ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
2514 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPL43 | TWNK | Q96RR1 | 806 |
| MRPL43 | SORCS3 | Q9UPU3 | 806 |
| MRPL43 | MRPL34 | Q9BQ48 | 581 |
| MRPL43 | ZNF688 | P0C7X2 | 497 |
| MRPL43 | SLC25A4 | P12235 | 497 |
| MRPL43 | MRPS2 | Q9Y399 | 496 |
| MRPL43 | POLG | P54098 | 494 |
| MRPL43 | MRPS10 | P82664 | 491 |
| MRPL43 | MRPL49 | Q13405 | 484 |
| MRPL43 | MRPL55 | Q7Z7F7 | 484 |
| MRPL43 | MRPL13 | Q9BYD1 | 480 |
| MRPL43 | MRPS21 | P82921 | 476 |
| MRPL43 | RPL35A | P18077 | 470 |
| MRPL43 | MRPL41 | Q8IXM3 | 446 |
| MRPL43 | RPL9 | P32969 | 433 |
IntAct
88 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| YBX1 | HNRNPR | psi-mi:“MI:0914”(association) | 0.770 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| MRPL43 | FXR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FXR2 | MRPL43 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NP | KPNA6 | psi-mi:“MI:0914”(association) | 0.550 |
| RPS6 | IPO7 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL50 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL13 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL18 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| VCAM1 | PSMD11 | psi-mi:“MI:0914”(association) | 0.530 |
| NDUFAB1 | MIEF1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| VASP | MRPL43 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| MRPL43 | SRPK1 | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| Ybx1 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.400 |
| MRPL43 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| ALYREF | psi-mi:“MI:0914”(association) | 0.350 | |
| CAND1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS5 | FBLL1 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRK2 | psi-mi:“MI:0914”(association) | 0.350 | |
| TFAM | MRPS14 | psi-mi:“MI:0914”(association) | 0.350 |
| SSBP1 | MRPS14 | psi-mi:“MI:0914”(association) | 0.350 |
| ATAD3A | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| PXN | GAK | psi-mi:“MI:0914”(association) | 0.350 |
| PRKCI | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| ARHGAP27 | MCRIP1 | psi-mi:“MI:0914”(association) | 0.350 |
| H1-6 | SRSF10 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (211): MRPL43 (Two-hybrid), NACC1 (Affinity Capture-MS), SLK (Affinity Capture-MS), MRPL39 (Affinity Capture-MS), GLS (Affinity Capture-MS), MRPL44 (Affinity Capture-MS), MRPL20 (Affinity Capture-MS), NDUFAF5 (Affinity Capture-MS), MRPL4 (Affinity Capture-MS), MRPL42 (Affinity Capture-MS), MALSU1 (Affinity Capture-MS), MRPS30 (Affinity Capture-MS), MRPL43 (Affinity Capture-MS), MRPL43 (Affinity Capture-MS), MRPL43 (Affinity Capture-MS)
ESM2 similar proteins: A4IFR8, A4IG66, C0SPG1, D3Z8Y2, D4A039, K7SGN7, O09111, P49406, P82913, P82914, P82918, P83565, Q0MQJ3, Q0MQJ4, Q0MQJ5, Q12766, Q12789, Q1XHY1, Q2HJI0, Q2TBI6, Q32L09, Q58D79, Q5R8M4, Q5R8S0, Q5TM62, Q6P1H6, Q767K8, Q768S4, Q7Z7J5, Q8C008, Q8CAK3, Q8HXG5, Q8N163, Q8N983, Q8ND04, Q8TF30, Q8VDP4, Q99N84, Q99N85, Q9DC71
Diamond homologs: Q8N983, Q95KE5, Q99N89, Q9UUC8, Q7S300, Q06090, Q5A3J1, Q758S3
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPL43 | “form complex” | “39S mitochondrial large ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 89 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial ribosome-associated quality control | 27 | 46.7× | 5e-37 |
| Mitochondrial translation initiation | 25 | 44.7× | 7e-34 |
| Mitochondrial translation elongation | 25 | 44.7× | 7e-34 |
| Mitochondrial translation | 23 | 44.6× | 4e-31 |
| Mitochondrial translation termination | 25 | 38.7× | 3e-32 |
| Translation | 25 | 21.9× | 1e-25 |
| Mitochondrial protein degradation | 6 | 9.7× | 2e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 25 | 53.0× | 1e-34 |
| translation | 18 | 22.6× | 2e-17 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
145 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 122 |
| Likely benign | 2 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2312 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:100977630:A:AG | acceptor_gain | 1.0000 |
| 10:100977630:AGAC:A | acceptor_gain | 1.0000 |
| 10:100977631:G:GG | acceptor_gain | 1.0000 |
| 10:100977631:GACG:G | acceptor_gain | 1.0000 |
| 10:100977731:G:GG | donor_gain | 1.0000 |
| 10:100978289:CCCTA:C | acceptor_loss | 1.0000 |
| 10:100978293:A:AG | acceptor_gain | 1.0000 |
| 10:100978293:AG:A | acceptor_gain | 1.0000 |
| 10:100978293:AGGAT:A | acceptor_gain | 1.0000 |
| 10:100978294:G:GA | acceptor_gain | 1.0000 |
| 10:100978294:GG:G | acceptor_gain | 1.0000 |
| 10:100978294:GGA:G | acceptor_gain | 1.0000 |
| 10:100978294:GGAT:G | acceptor_gain | 1.0000 |
| 10:100978294:GGATG:G | acceptor_gain | 1.0000 |
| 10:100978388:GGTG:G | donor_loss | 1.0000 |
| 10:100978389:G:GA | donor_loss | 1.0000 |
| 10:100978389:G:GG | donor_gain | 1.0000 |
| 10:100978390:T:G | donor_loss | 1.0000 |
| 10:100978950:G:GT | donor_gain | 1.0000 |
| 10:100979100:AG:A | acceptor_gain | 1.0000 |
| 10:100979101:GG:G | acceptor_gain | 1.0000 |
| 10:100979101:GGGA:G | acceptor_gain | 1.0000 |
| 10:100979229:GCC:G | donor_gain | 1.0000 |
| 10:100979258:C:G | donor_gain | 1.0000 |
| 10:100979269:GTG:G | donor_gain | 1.0000 |
| 10:100979844:CTAGG:C | acceptor_loss | 1.0000 |
| 10:100979845:TA:T | acceptor_loss | 1.0000 |
| 10:100979846:A:AG | acceptor_gain | 1.0000 |
| 10:100979846:A:C | acceptor_loss | 1.0000 |
| 10:100979846:AG:A | acceptor_gain | 1.0000 |
AlphaMissense
1026 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:100986826:A:G | W130R | 0.997 |
| 10:100986826:A:T | W130R | 0.997 |
| 10:100986839:G:C | S125R | 0.997 |
| 10:100986839:G:T | S125R | 0.997 |
| 10:100986841:T:G | S125R | 0.997 |
| 10:100986824:C:A | W130C | 0.995 |
| 10:100986824:C:G | W130C | 0.995 |
| 10:100987414:G:C | F10L | 0.994 |
| 10:100987414:G:T | F10L | 0.994 |
| 10:100987416:A:G | F10L | 0.994 |
| 10:100987098:G:T | A77D | 0.992 |
| 10:100987190:G:C | F46L | 0.992 |
| 10:100987190:G:T | F46L | 0.992 |
| 10:100987192:A:G | F46L | 0.992 |
| 10:100987092:T:G | Y79S | 0.990 |
| 10:100987093:A:C | Y79D | 0.989 |
| 10:100987164:G:T | A55D | 0.989 |
| 10:100987361:C:G | R28P | 0.989 |
| 10:100987362:G:T | R28S | 0.988 |
| 10:100987140:A:T | I63K | 0.987 |
| 10:100987191:A:G | F46S | 0.987 |
| 10:100987352:A:G | F31S | 0.987 |
| 10:100987093:A:G | Y79H | 0.986 |
| 10:100986825:C:A | W130L | 0.985 |
| 10:100987167:A:G | F54S | 0.985 |
| 10:100986825:C:G | W130S | 0.984 |
| 10:100987099:C:G | A77P | 0.984 |
| 10:100987391:C:T | G18E | 0.984 |
| 10:100986833:C:A | Q127H | 0.983 |
| 10:100986833:C:G | Q127H | 0.983 |
dbSNP variants (sampled 300 via entrez): RS1000263318 (10:100980496 A>G), RS1000469814 (10:100986024 G>T), RS1000734618 (10:100987112 C>A,T), RS1001463681 (10:100986729 A>G), RS1001745445 (10:100985696 A>G,T), RS1001831379 (10:100986972 T>C,G), RS1002588925 (10:100977830 G>A), RS1003167771 (10:100984188 C>T), RS1003712073 (10:100982598 C>G), RS1003743134 (10:100982311 G>A), RS1003774635 (10:100987998 G>C), RS1003924220 (10:100988126 A>C,G), RS1004112787 (10:100983123 C>T), RS1004280892 (10:100983000 C>A,G), RS1004659697 (10:100978295 G>A,C)
Disease associations
OMIM: gene MIM:611848 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006921_7 | Regular attendance at a pub or social club | 1.000000e-08 |
| GCST010002_298 | Refractive error | 3.000000e-22 |
| GCST011878_8 | Mitochondrial heteroplasmy measurement | 3.000000e-12 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009592 | social interaction measurement |
| EFO:0600008 | mitochondrial heteroplasmy measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | affects cotreatment, decreases expression | 3 |
| Valproic Acid | increases methylation, increases expression | 3 |
| FR900359 | increases phosphorylation | 1 |
| beta-lapachone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| bisphenol S | decreases methylation | 1 |
| Vorinostat | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Atrazine | increases expression | 1 |
| Dimethyl Sulfoxide | affects expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | increases abundance, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.